[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363996-105":59,"doc-detail-363996-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","low-kif4a-expression-is-associated-with-gastric-cancer-progression-and-aggressive-phenotypes","Low KIF4A expression is associated with gastric cancer progression and aggressive phenotypes","","Kinesin family member 4A (KIF4A) regulates chromosome condensation and segregation during mitosis and is upregulated as an oncogene in multiple malignancies, yet its role in gastric cancer remains unclear. This study evaluates the clinicopathological and prognostic significance of KIF4A expression in gastric cancer using immunohistochemistry with QuPath-based digital image analysis. Low KIF4A expression links to adverse features and worse survival, with additional bioinformatics and mRNA-level validation supporting prognostic associations and distinct pathway patterns including EMT activation and E2F-mediated proliferation.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/low-kif4a-expression-is-associated-with-gastric-cancer-progression-and-aggressive-phenotypes/363996/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/low-kif4a-expression-is-associated-with-gastric-cancer-progression-and-aggressive-phenotypes/363996.png","ImageObject",300,407,{"name":92,"@type":93},"RuangKosong","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-18","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What was the goal of evaluating KIF4A in gastric cancer?","Question",{"text":112,"@type":113},"To determine the clinicopathological and prognostic significance of KIF4A expression in gastric cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was KIF4A expression measured?",{"text":117,"@type":113},"KIF4A protein expression was assessed by immunohistochemistry and quantified using QuPath-based digital image analysis.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the relationship between low KIF4A expression and patient outcomes?",{"text":121,"@type":113},"Low KIF4A expression was significantly associated with adverse clinicopathological features and poor survival outcomes, supported by mRNA-level analyses in public databases.",{"name":123,"@type":110,"acceptedAnswer":124},"Which biological processes were linked to different levels of KIF4A?",{"text":125,"@type":113},"Enrichment analysis associated low KIF4A expression with EMT activation, while high expression correlated with E2F-mediated proliferation.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},363996,1790416716,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},962090883219,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nLow KIF4A expression is associated with gastric cancer progression and aggressive phenotypes  \nSeongsik Bang1, SeoungWan Chae1, Yeseul Kim2, Seungyun Jee3, Hosub Park4, Hyunsung Kim4, Seung Sam Paik4, Bo Gun Jang5 & Jaekyung Myung4􀀍  \nKinesin family member 4A (KIF4A) regulates chromosome condensation and segregation during mitosis and is upregulated as an oncogene in various malignancies. However, its role in gastric cancer (GC) remains unclear. Therefore, this study aims to evaluate the clinicopathological and prognostic significance of KIF4A expression in GC. KIF4A protein expression was assessed via immunohistochemistry and quantified using QuPath-based digital image analysis. KIF4A expression was analyzed for its associations with clinicopathological and molecular characteristics, as well as its prognostic significance. Additionally, bioinformatics tools were used to confirm the prognostic value of KIF4A atthe mRNA level and perform enrichment and comprehensive immune analyses. Low KIF4A expression was significantly associated with adverse clinicopathological features and inversely correlated with HER2 amplification. Survival analysis revealed that patients with low KIF4A expression had poor clinical outcomes, consistent with mRNA-level analyses from publicly available databases. Univariate Cox regression revealed low KIF4A expression as a significant prognostic factor. However, low KIF4A expression was no longer significant in multivariate analysis. In enrichment analysis, low KIF4A expression is associated with EMT activation, whereas high expression correlates with E2Fmediated proliferation. Although high KIF4A expression suggests an immune-inflamed phenotype, its predictive ability was limited in an independent validation cohort.  \nKeywords Gastric cancer, Prognosis, Immunohistochemistry, Digital pathology, Kinesin family member 4A, KIF4A 4  \nGastric cancer (GC) is a common digestive system malignancy, ranking fifth in global incidence and mortality, based on the 2022 Global Cancer Statistics (GLOBOCAN 2022)1. GC is anatomically classified as cardia and non-cardia subtypes, with distinct epidemiological and etiological features. Helicobacter pylori infection is the main cause of non-cardia GC, while obesity and gastroesophageal reflux disease are key risk factors for cardia GC2. Furthermore, genetic predisposition has recently gained recognition3.  \nGastric adenocarcinoma, arising from the mucosa, is the predominant histologic type of GC and exhibits substantial histologic and molecular heterogeneity. Histologically, gastric adenocarcinoma is classified as intestinal or diffuse types based on the Lauren classification system4, while the World Health Organization (WHO) classification system provides detailed morphological subtypes5. At the molecular level, the Cancer Genome Atlas (TCGA) Research Network identified four distinct subtypes: Epstein-Barr virus (EBV)-positive, microsatellite instability (MSI), genomically stable (GS), and chromosomal instability (CIN)6.  \nSurgical resection is the main curative treatment for early and locally advanced GC, while adjuvant chemotherapy is recommended to improve survival in advanced GC. Recently, the treatment landscape has expanded to include immunotherapies and agents targeting HER2 and CLDN18.27–9. However, the prognosis for patients with advanced or metastatic disease remains poor. Therefore, identifying clinically useful predictive and prognostic biomarkers is essential for improving patient management.  \nIn recent years, studies on GC have highlighted cellular heterogeneity, microenvironmental adaptation, and epithelial-mesenchymal transition (EMT) as key contributors to tumor progression. Within a single  \n1Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. 2Department of Pathology, Korea University Anam Hospital, Korea Univ","cbCaiqkxiIWHgtSv","https://ap.wps.com/l/cbCaiqkxiIWHgtSv","pdf",1985671,11,"English","# Background\n## Gastric cancer characteristics\n## Treatments and need for biomarkers\n# Methods\n## KIF4A assessment by immunohistochemistry\n## Bioinformatics and immune analysis\n# Results\n## Associations with clinicopathological and molecular features\n## Survival and regression analyses\n## Enrichment and pathway correlations\n## Immune phenotype prediction and validation\n# Discussion\n## EMT activation and proliferation pathways\n## Clinical implications and limitations","[{\"question\":\"What was the goal of evaluating KIF4A in gastric cancer?\",\"answer\":\"To determine the clinicopathological and prognostic significance of KIF4A expression in gastric cancer.\"},{\"question\":\"How was KIF4A expression measured?\",\"answer\":\"KIF4A protein expression was assessed by immunohistochemistry and quantified using QuPath-based digital image analysis.\"},{\"question\":\"What is the relationship between low KIF4A expression and patient outcomes?\",\"answer\":\"Low KIF4A expression was significantly associated with adverse clinicopathological features and poor survival outcomes, supported by mRNA-level analyses in public databases.\"},{\"question\":\"Which biological processes were linked to different levels of KIF4A?\",\"answer\":\"Enrichment analysis associated low KIF4A expression with EMT activation, while high expression correlated with E2F-mediated proliferation.\"}]","Low KIF4A expression is associated with gastric cancer progression and aggressive phenotypes | PDF",1790154902,28,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ab51193750478bfeb97a39f9a5360af.webp",983,1291,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aaf2c5a5735f8835dbd8332f273f658c.webp",982,1290,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4666ed8d51a0df8f1bfb1efb84e736cf.webp",981,1289,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/946acbf4d3a2dfb8c7362a56c9ba76d4.webp",980,1287]